Superficial thrombophlebitis
Appearance
Risk factors
[edit | edit source]- Endothelial injury
- Trauma
- Insertion of venous catheter
- Venous stasis
- Varicosities
- Hypercoagulable states
- Need to evaluate all those patients who don't have a risk factor
Specific scenarios
[edit | edit source]- Superficial thrombophlebitis with varicose veins
- Mostly a/w VV
- Manifests as tender nodules with localised induration and erythema
- Mostly GSV but can occur in SSV
- DUS, follow-up with short-term repeat DUS, and anticoagulation if the SVT approaches deep veins
- Traumatic thrombophlebitis
- Often seen in IVDU or hospital patients
- Pain, tenderness and erythema at the site
- Anticoagulation depends on severity of symptoms and underlying hypercoagulable conditions
- May take weeks to months to resolve
- Septic and suppurative thrombophlebitis
- Intense pain at IV site, fever, leucocytosis
- Excision of the vein is rarely needed
- Migratory thrombphlebitis
- Repeated thrombosis developing in superficial veins at varying sites but most commonly in the lower extremity
- May be associated with carcinoma (Trousseau syndrome) - evaluate for occult malignancy
- Also seen in Behcet disease, Buerger disease and polyarteritis nodosa
- Mondor disease
- Thrombophlebitis of the thoracoepigastric vein of the breast and chest wall
- Associated with breast cancer or hypercoagulable states
- Name has also been applied to SVT of the dorsal vein of the penis, which can occur after hernia operations, and in association with excessive sexual intercourse. Treat with NSAIDs. Rarely needs excision of the vein.
- Upper extremity superficial thrombophlebitis
- Typically occurs after cannulation and infusion of caustic substances that damage the endothelium
- Progression to DVT is less common than in the lower limb
- Remove the line and consider anticoagulation
Treatment
[edit | edit source]- Goals
- Decrease acute symptoms
- Prevent extension
- Prevent DVT/PE
- NSAIDs
- Reduce the risk of SVT extension or recurrence by 67%
- Small SVTs with obvious inciting factors such as IVC should be treated with 6/52 NSAIDs
- Anticoagulation
- Rutherford's suggests prophylactic LMWH for 45 days in patients with >5cm of SVT
- UTD suggests anticoagulation for patients that remain symptomatic after basic steps have been taken, or if they are considered high-risk for DVT/PE progression
Complications
[edit | edit source]- Risks of extension into deep veins - DVT/PE
- Depends on anatomic location - GSV can extend into femoral vein in about 10%
- There are reports of PE/DVT after SVT in arm veins too